Devon Orzano
Acute Care · Neptune, NJNPI 1013194927
Payments from drug & device makers
Across 43 payments — averaging $40.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$695
- Abbott$447
- Nevro Corp.$196
- Insightec,inc$129
- Microtransponder, Inc.$95
- Integra Lifesciences Corporation$76
- plus $115 from 6 others
What the payments were for
- Food & beverage$1,754100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 20 | $695 |
| Abbott | 7 | $447 |
| Nevro Corp. | 4 | $196 |
| Insightec,inc | 2 | $129 |
| Microtransponder, Inc. | 1 | $95 |
| Integra Lifesciences Corporation | 2 | $76 |
| Corcept Therapeutics | 2 | $38 |
| AstraZeneca | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Theragen, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$310
- SenSight$130
- Exablate$118
- Senza$115
- PERCEPT PC BRAINSENSE$108
How this compares
$1,754 in reported general payments places this provider in the 85th percentile of 656 acute care providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 32 | $390 |
| Pregabalin | 11 | $147 |
| Oxycodone Hcl | 20 | $126 |
| Mupirocin | 14 | $108 |
| Tizanidine Hcl | 16 | $89 |
| Methylprednisolone | 11 | $42 |
| Diazepam | 11 | $13 |
Paid to pharmacies, not to this prescriber.
Other acute care in Neptune
- Ellen McCueNeptune$26K
- Venus BalaoingNeptune$10K
- Angela NelsonNeptune$6K
- Katrina MichalikNeptune$4K
- Charles WarwickNeptune$3K
- Gabriella MagarelliHackensack$44K
- Per RosenkvistLivingston$29K
- Matthew OstroffPaterson$27K
- Suzanne ShuggLivingston$25K
- Maria Tedi CoronelHackensack$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.